Alpha Teknova, Inc.
TKNO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001850902
No open-market purchases or sales by Alpha Teknova, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $51.7M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Alpha Teknova, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 31 | 28 | −3 |
| Shares | 5.99M | 5.86M | −129.5K (−2.2%) |
| Value | $15.6M | $8.03M | −$7.54M (−48.4%) |
New holders (2)
Institutions that held Alpha Teknova, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 12,003 | $23.3K | 0.00% |
| Citadel Advisors LLC | 10,112 | $13.9K | 0.00% |
Sold out (5)
Institutions that held Alpha Teknova, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Premier Fund Managers Ltd | 47,483 | $117.0K |
| State Board of Administration of Florida Retirement System | 13,310 | $39.4K |
| Brown Advisory Inc | 11,133 | $29.5K |
| Wells Fargo & Company | 197 | $522 |
| FMR LLC | 46 | $116 |